NASDAQ: KZIA
Kazia Therapeutics Ltd Stock Forecast, Predictions & Price Target

Analyst price target for KZIA

Based on 1 analyst offering 12 month price targets for Kazia Therapeutics Ltd

Min Forecast
$3.00+201.51%
Avg Forecast
$3.00+201.51%
Max Forecast
$3.00+201.51%

Should I buy or sell KZIA stock?

Based on 1 analyst offering ratings for Kazia Therapeutics Ltd.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their KZIA stock forecasts and price targets.

KZIA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-02-06

1 of 1

Forecast return on equity

Is KZIA forecast to generate an efficient return?

Company
0%
Industry
88.9%
Market
65.16%
KZIA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is KZIA forecast to generate an efficient return on assets?

Company
0%
Industry
23.25%
KZIA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

KZIA earnings per share forecast

What is KZIA's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$3.30

KZIA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
KZIA$1.00$3.00+201.51%Strong Buy
TTNP$3.63N/AN/A
MBRX$1.13$8.00+607.96%Strong Buy
INM$2.82N/AN/A
TOVX$1.15$6.00+419.93%Strong Buy

Kazia Therapeutics Stock Forecast FAQ

Is Kazia Therapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: KZIA) stock is to Strong Buy KZIA stock.

Out of 1 analyst, 1 (100%) are recommending KZIA as a Strong Buy, 0 (0%) are recommending KZIA as a Buy, 0 (0%) are recommending KZIA as a Hold, 0 (0%) are recommending KZIA as a Sell, and 0 (0%) are recommending KZIA as a Strong Sell.

If you're new to stock investing, here's how to buy Kazia Therapeutics stock.

What is KZIA's earnings growth forecast for 2025-2025?

(NASDAQ: KZIA) Kazia Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 19.72%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 24.9%.

Kazia Therapeutics's earnings in 2025 is -$17,388,311.

In 2025, KZIA is forecast to generate -$1,098,407,587 in earnings, with the lowest earnings forecast at -$1,098,407,587 and the highest earnings forecast at -$1,098,407,587.

What is KZIA's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: KZIA) forecast ROE is 0%, which is considered weak.

What is KZIA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year KZIA price target, the average KZIA price target is $3.00, with the highest KZIA stock price forecast at $3.00 and the lowest KZIA stock price forecast at $3.00.

The Wall Street analyst predicted that Kazia Therapeutics's share price could reach $3.00 by Feb 6, 2026. The average Kazia Therapeutics stock price prediction forecasts a potential upside of 201.51% from the current KZIA share price of $1.00.

What is KZIA's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: KZIA) Kazia Therapeutics's current Earnings Per Share (EPS) is -$6.60. In 2025, KZIA's EPS is forecast to hit -$3.30 (min: -$3.30, max: -$3.30).

What is KZIA's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: KZIA) forecast ROA is 0%, which is lower than the forecast US Biotechnology industry average of 23.25%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.